Read articles from United States of America

August 28, 2026 by substack.com

A JAMA article supporting clinician conversations about e-cigarettes should make the debate more precise. The evidence is strongest for adult smokers who use vaping as a route away from cigarettes, not for vague claims about nicotine use in general. That distinction matters because policy can either support full switching or bury it under uncertainty. Medical guidance should separate evidence from values clearly enough for smokers to understand their options.

August 27, 2026 by ocregister.com

Smokers should not have to fight bureaucracy to reach safer choices. Regulation has a role in setting standards, preventing youth access and protecting consumers, but it should not become a barrier that leaves cigarettes as the easiest product to buy. Harm reduction depends on making lower-risk alternatives available, understandable and legally viable. Public health loses its purpose when process blocks the very options that could reduce harm.

August 27, 2026 by ocregister.com

Smokers should not have to fight bureaucracy to reach safer choices. Regulation has a role in setting standards, preventing youth access and protecting consumers, but it should not become a barrier that leaves cigarettes as the easiest product to buy. Harm reduction depends on making lower-risk alternatives available, understandable and legally viable. Public health loses its purpose when process blocks the very options that could reduce harm.

August 25, 2026 by substack.com

A flavour is not an age group, and regulation becomes weaker when it treats the two as the same. Adults who smoke often rely on flavoured products because taste can make switching away from cigarettes more acceptable and sustainable. Youth access should be prevented through age checks, retailer enforcement and penalties for illegal sales, not by removing options from adults. Public health needs precision: protect young people without making harm reduction less workable for smokers.

August 24, 2026 by regulatorwatch.com

The court ruling against the FDA’s approach to flavoured vapes could mark an important turning point for evidence-based regulation. Flavours are not a minor detail for many adults who switch from smoking; they can affect whether lower-risk products are acceptable enough to replace cigarettes. Youth protection remains essential, but it should be pursued through enforcement and product standards rather than blanket hostility to adult choice. A credible regulatory system should assess risk, behaviour and public health impact instead of treating flavour as automatic failure.

August 24, 2026 by goodgoodgood.co

Historic-low youth smoking rates should be recognised as major public health progress. The latest US data also show falling youth vaping, challenging the idea that adult access to lower-risk nicotine products inevitably drives a youth crisis. Prevention still matters, especially for those who already vape frequently, but the message should be proportionate. Protecting young people and helping adult smokers leave cigarettes behind can be part of the same strategy.

August 20, 2026 by theconversation.com

Lower youth smoking and vaping rates in the US deserve attention because they challenge the assumption that harm reduction for adults must come at the cost of youth protection. The real question is what policies, norms and enforcement patterns are helping to reduce adolescent use while still recognising that adult smokers need alternatives to cigarettes. Youth prevention and adult harm reduction should not be treated as opposing goals. A serious nicotine strategy has to protect young people without distorting the risk message for everyone else.

August 19, 2026 by gfn.tv

Enforcement cannot fix a market that policy itself is helping to create. Illicit nicotine trade grows where demand remains high, legal access is restricted and safer products are pushed outside accountable channels. Police action may disrupt supply, but it cannot remove the incentives that make illegal sales profitable. A serious response to the illicit market crisis has to combine enforcement with harm reduction, realistic regulation and legal options that adults will actually use.

August 18, 2026 by smokefreesweden.org

A JAMA publication should raise the standard of the nicotine debate, not narrow it into alarm. Research on smoking, vaping or smoke-free products needs to be read through the lens of comparison: what happens to people who continue smoking, switch completely, or use products alongside cigarettes. The public health value lies in that distinction. Evidence should clarify the movement away from combustion, not be used to make every nicotine product appear equally harmful.

August 14, 2026 by thewellnews.com

Vaping bans are often built on claims that sound settled but weaken under closer scrutiny. New research challenges the assumptions used to justify prohibition, especially around youth use, switching and the role of flavours for adults who smoke. Evidence should be allowed to disturb comfortable policy narratives. Public health cannot reduce harm by defending myths that make lower-risk alternatives harder to access.